The effect of COVID-19 on the law has been transformative and wide-ranging, but as a Harvard Law School panel pointed out on the one-year anniversary of campus shutdown, the changes haven’t all been for the worse.
Disheartened by tales from family and friends frustrated by his home state of Pennsylvania’s vaccine distribution system, Seth Rubinstein ’22, a second year student at Harvard Law School, knew he wanted to get involved.
Harvard Law alum Daniel Aaron ’20 thinks high obesity rates among people of color may be another legacy of ongoing racism in America.
Since President Joe Biden took office in January, dozens of Harvard Law community members, including faculty and alumni, have been tapped to serve in high-profile positions in his administration
On February 11, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced the formation of its new advisory board.
Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine? Harvard Law public health expert Carmel Shachar says the answer is yes.
The Petrie-Flom Center at Harvard Law School is joining forces with the Solomon Center for Health Law and Policy, its counterpart at Yale Law School, to host a seminar series reflecting on ethical and legal issues raised by the COVID-19 pandemic.
Public health expert Carmel Shachar discusses the COVID-19 vaccine, who is likely to get it first, and whether people can be required to get vaccinated.
Experts gathered this week to discuss the ethical, social, and legal implications of technological advancements that facilitate the early detection of dementia.
Cass Sunstein ’78, Robert Walmsley University Professor and former Administrator of the White House Office of Information and Regulatory Affairs in the Obama administration, believes “Nudge theory” might help bridge the gap between supply and demand for organ transplants.
